ORKA
Oruka Therapeutics Inc.
$17.15
+$1.60(+10.29%)
58
Overall
--
Value
58
Tech
--
Quality
Market Cap
$558.02M
Volume
566.64K
52W Range
$5.49 - $31.13
Target Price
$42.63
Order:
Income Statement
| Metric | Trend | Chart | 2014 Dec | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-9.7M | $-11.5M | $-16.6M | $-18.7M | $-8.1M | $5.8M | $9.8M | $19.3M | $10.6M | $7.3M | ||
| Research & Development | $5.6M | $7.1M | $12.3M | $14.1M | $4.2M | $1.8M | $5.0M | $13.8M | $4.7M | $1.0M | ||
| Research Expense | $5.6M | $7.1M | $12.3M | $14.1M | $4.2M | $1.8M | $5.0M | $13.8M | $4.7M | $1.0M | ||
| Selling, General & Administrative | $4.1M | $4.4M | $4.3M | $4.6M | $3.9M | $4.0M | $4.8M | $5.5M | $5.8M | $6.3M | ||
| General & Administrative Expenses | $4.1M | $4.4M | $4.3M | $4.6M | $3.9M | $4.0M | $4.8M | $5.5M | $5.8M | $6.3M | ||
| Salaries & Wages | $-647.0K | $-599.0K | $-576.0K | $-458.0K | $-273.0K | $-151.0K | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-12.0K | $-19.0K | $-24.0K | $-27.0K | $-22.0K | $-18.0K | $8.0K | $16.0K | $20.0K | $15.0K | ||
| Depreciation & Amortization | $-12.0K | $-19.0K | $-24.0K | $-27.0K | $-22.0K | $-18.0K | $8.0K | $16.0K | $20.0K | $15.0K | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-9.7M | $-11.5M | $-16.6M | $-18.7M | $-8.1M | $-5.8M | $-9.8M | $-19.3M | $-10.6M | $-7.3M | ||
| EBITDA | $-9.6M | $-11.2M | $-16.0M | $-18.1M | $-7.9M | $-5.6M | $-9.6M | $-19.2M | $-10.5M | $-5.4M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $3.0K | $4.0K | -- | $6.0K | $8.0K | $7.0K | $9.0K | -- | -- | -- | ||
| Intinc | $7.0K | $14.0K | $169.0K | $167.0K | $162.0K | $172.0K | $28.0K | $13.0K | $675.0K | $2.0M | ||
| Net Non-Operating Interest Income/Expense | $4.0K | $10.0K | $169.0K | $161.0K | $154.0K | $165.0K | $19.0K | $13.0K | $675.0K | $2.0M | ||
| Other Income/Expense | -- | -- | -- | -- | -- | -- | -- | -- | $-5.0K | -- | ||
| Other Special Charges | -- | -- | -- | -- | -- | -- | -- | -- | $-5.0K | -- | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $159.0K | ||
| Special Income Charges | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-159.0K | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-9.7M | $-11.4M | $-16.4M | $-18.5M | $-8.0M | $-5.6M | $-9.7M | $-19.3M | $-10.6M | $-5.5M | ||
| Pre-Tax Income | $-9.7M | $-11.4M | $-16.4M | $-18.6M | $-8.0M | $-5.6M | $-9.7M | $-19.3M | $-9.9M | $-5.3M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-1.0M | $-188.0K | $-137.0K | $-61.0K | $-31.0K | $-167.0K | $-9.0K | $-695.0K | $-357.0K | $-192.0K | ||
| NET INCOME | ||||||||||||
| Net Income | $-9.7M | $-11.4M | $-16.4M | $-18.5M | $-7.9M | $-5.5M | $-9.7M | $-19.3M | $-9.9M | $-5.3M | ||
| Net Income (Continuing Operations) | $-9.7M | $-11.4M | $-16.4M | $-18.5M | $-7.9M | $-5.5M | $-9.7M | $-19.3M | $-9.9M | $-5.3M | ||
| Net Income (Discontinued Operations) | $-9.7M | $-11.4M | $-16.4M | $-18.5M | $-7.9M | $-5.5M | $-9.7M | $-19.3M | $-9.9M | $-5.3M | ||
| Net Income (Common Stockholders) | $-9.7M | $-11.4M | $-16.4M | $-18.5M | $-7.9M | $-5.5M | $-9.7M | $-19.3M | $-9.9M | $-5.3M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-9.7M | $-11.5M | $-16.6M | $-18.7M | $-8.1M | $5.8M | $9.8M | $19.3M | $10.6M | $7.3M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $1.7M | $524.1K | $755.6K | $869.3K | $1.2M | $110.1K | $392.5K | $1.2M | $1.2M | $14.4M | ||
| Average Shares Outstanding (Diluted) | $1.7M | $524.0K | $757.1K | $870.5K | $1.2M | $110.1K | $392.5K | $1.2M | $1.2M | $14.4M | ||
| Shares Outstanding | $1.8M | $754.7K | $760.9K | $1.2M | $1.5M | $132.8K | $1.2M | $1.2M | $1.2M | $14.5M | ||
| Basic EPS | -- | -- | -- | -- | -- | -- | $-24.84 | $-16.68 | $-8.28 | $-0.37 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-24.84 | $-16.68 | $-8.28 | $-0.37 | ||
| Diluted EPS | $-5.64 | $-21.84 | $-21.72 | $-21.24 | $-6.84 | $-49.8 | $-24.84 | $-16.68 | $-8.28 | $-0.37 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-49.8 | -- | -- | $-8.28 | $-0.37 | ||
| OTHER METRICS | ||||||||||||
| Other Gand A | $4.1M | $4.4M | $4.3M | $4.6M | $3.9M | $4.0M | $4.8M | $5.5M | $5.8M | $6.3M | ||
| Rent And Landing Fees | $4.1M | $4.4M | $4.3M | $4.6M | $3.9M | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | -- | -- | -- | -- | $159.0K | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORKA | $17.15 | +10.3% | 566.64K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |